{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:16:57Z","timestamp":1793729817847,"version":"4.6.1"},"reference-count":76,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>Scabies is a neglected tropical disease of the skin, causing severe itching and stigmatizing skin lesions. Further, scabies leads to impetigo, severe bacterial infections, and post-infectious complications. Around 200 million people are affected, particularly among disadvantaged populations living in crowded conditions in tropical areas. After almost 50 years, research into scabies control has shown great promise, particularly in highly-endemic island settings, but these findings have not been widely adopted. Newer approaches, utilizing ivermectin-based mass drug administration, appear feasible and highly effective. Inclusion of scabies in the WHO portfolio of neglected tropical diseases in 2017 may facilitate renewed opportunities and momentum toward global control. However, further operational research is needed to develop evidence-based strategies for control in a range of settings, and monitor their impact. Several enabling factors are required for successful implementation, including availability of affordable drug supply. Integration with existing health programs may provide a cost-effective approach to control.<\/jats:p>","DOI":"10.3390\/tropicalmed3030098","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T02:55:07Z","timestamp":1536202507000},"page":"98","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Control Strategies for Scabies"],"prefix":"10.3390","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-1287","authenticated-orcid":false,"given":"Daniel","family":"Engelman","sequence":"first","affiliation":[{"name":"Tropical Diseases, Murdoch Children\u2019s Research Institute, Parkville VIC 3052, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Parkville VIC 3052, Australia"},{"name":"Department of General Medicine, Royal Children\u2019s Hospital, Parkville VIC 3052, Australia"},{"name":"International Alliance for the Control of Scabies, Parkville VIC 3052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Steer","sequence":"additional","affiliation":[{"name":"Tropical Diseases, Murdoch Children\u2019s Research Institute, Parkville VIC 3052, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Parkville VIC 3052, Australia"},{"name":"Department of General Medicine, Royal Children\u2019s Hospital, Parkville VIC 3052, Australia"},{"name":"International Alliance for the Control of Scabies, Parkville VIC 3052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1469-0691.2012.03798.x","article-title":"Scabies in the developing world\u2014Its prevalence, complications, and management","volume":"18","author":"Hay","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMcp052784","article-title":"Clinical practices. Scabies","volume":"354","author":"Chosidow","year":"2006","journal-title":"New Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Davis, J.S., McGloughlin, S., Tong, S.Y., Walton, S.F., and Currie, B.J. (2013). A novel clinical grading scale to guide the management of crusted scabies. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002387"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1365-2133.2008.08541.x","article-title":"New insights into disease pathogenesis in crusted (Norwegian) scabies: The skin immune response in crusted scabies","volume":"158","author":"Walton","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-4632.2011.05017.x","article-title":"Impaired quality of life in adults and children with scabies from an impoverished community in Brazil","volume":"51","author":"Worth","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/inthealth\/ihv071","article-title":"Social stigma towards neglected tropical diseases: A systematic review","volume":"8","author":"Hofstraat","year":"2016","journal-title":"Int. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/bjd.14361","article-title":"Quality of life impact of childhood skin conditions measured using the Children\u2019s Dermatology Life Quality Index (CDLQI): A meta-analysis","volume":"174","author":"Olsen","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Steer, A.C., Jenney, A.W., Kado, J., Batzloff, M.R., La Vincente, S., Waqatakirewa, L., Mulholland, E.K., and Carapetis, J.R. (2009). High burden of impetigo and scabies in a tropical country. PLoS Negl. Trop. Dis., 3.","DOI":"10.1371\/journal.pntd.0000467"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Swe, P.M., Zakrzewski, M., Kelly, A., Krause, L., and Fischer, K. (2014). Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002897"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Swe, P.M., and Fischer, K. (2014). A scabies mite serpin interferes with complement-mediated neutrophil functions and promotes staphylococcal growth. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002928"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QCO.0b013e32835e085b","article-title":"Scabies: A suitable case for a global control initiative","volume":"26","author":"Hay","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QCO.0b013e3283511d27","article-title":"Streptococcal skin infection and rheumatic heart disease","volume":"25","author":"Parks","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/jpc.13851","article-title":"Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children","volume":"54","author":"Thornley","year":"2018","journal-title":"J. Paediatr. Child Health"},{"key":"ref_14","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1545\u20131602."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","article-title":"The global burden of scabies: A cross-sectional analysis from the Global Burden of Disease Study 2015","volume":"17","author":"Karimkhani","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: A systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mason, D.S., Marks, M., Sokana, O., Solomon, A.W., Mabey, D.C., Romani, L., Kaldor, J., Steer, A.C., and Engelman, D. (2016). The prevalence of scabies and impetigo in the solomon islands: A population-based survey. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004803"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Yeoh, D.K., Anderson, A., Cleland, G., and Bowen, A.C. (2017). Are scabies and impetigo \u2018normalised\u2019? A cross-sectional comparative study of hospitalised children in northern Australia assessing clinical recognition and treatment of skin infections. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005726"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/ced.13152","article-title":"Systematic review of the diagnosis of scabies in therapeutic trials","volume":"42","author":"Thompson","year":"2017","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4269\/ajtmh.16-0753","article-title":"The epidemiology of scabies and impetigo in relation to demographic and residential characteristics: Baseline findings from the Skin Health Intervention Fiji Trial","volume":"97","author":"Romani","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Romani, L., Koroivueta, J., Steer, A.C., Kama, M., Kaldor, J.M., Wand, H., Hamid, M., and Whitfeld, M.J. (2015). Scabies and impetigo prevalence and risk factors in Fiji: A national survey. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003452"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Aung, P.T.Z., Cuningham, W., Hwang, K., Andrews, R.M., Carapetis, J.R., Kearns, T., Clucas, D., McVernon, J., Simpson, J.A., and Tong, S.Y.C. (2018). Scabies and risk of skin sores in remote Australian Aboriginal communities: A self-controlled case series study. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006668"},{"key":"ref_23","unstructured":"World Health Organization (2018, March 17). Report of the Tenth Meeting of the WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases. Available online: http:\/\/www.who.int\/neglected_diseases\/NTD_STAG_report_2017.pdf?ua=1."},{"key":"ref_24","unstructured":"World Health Organization (2018, August 12). 9th NTD-STAG Global Working Group Meeting on Monitoring and Evaluation of Neglected Tropical Diseases. Available online: http:\/\/www.who.int\/neglected_diseases\/events\/STAG_Working_Group_on_Monitoring_Evaluation\/en\/."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Engelman, D., Kiang, K., Chosidow, O., McCarthy, J., Fuller, C., Lammie, P., Hay, R., and Steer, A. (2013). Members of the International Alliance for The Control of Scabies. Toward the global control of human scabies: Introducing the International Alliance for the Control of Scabies. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002167"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Engelman, D., Fuller, L.C., and Steer, A.C. (2018). Consensus criteria for the diagnosis of scabies: A Delphi study of international experts. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006549"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0140-6736(91)92669-S","article-title":"Community control of scabies: A model based on use of permethrin cream","volume":"337","author":"Taplin","year":"1991","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0190-9622(83)70167-2","article-title":"Eradication of scabies with a single treatment schedule","volume":"9","author":"Taplin","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","first-page":"34","article-title":"Control of scabies, skin sores and haematuria in children in the Solomon Islands: Another role for ivermectin","volume":"83","author":"Lawrence","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2133.2000.03704.x","article-title":"The use of ivermectin in controlling an outbreak of scabies in a prison","volume":"143","author":"Leppard","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0140-6736(90)91253-7","article-title":"Safety of and compliance with community-based ivermectin therapy","volume":"335","author":"Pacque","year":"1990","journal-title":"Lancet"},{"key":"ref_32","first-page":"721","article-title":"Community-based treatment of onchocerciasis with ivermectin: Acceptability and early adverse reactions","volume":"67","author":"Pacque","year":"1989","journal-title":"Bull. World Health Organ."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Marks, M., Taotao-Wini, B., Satorara, L., Engelman, D., Nasi, T., Mabey, D.C., and Steer, A.C. (2015). Long term control of scabies fifteen years after an intensive treatment programme. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0004246"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Andrews, R.M., Kearns, T., Connors, C., Parker, C., Carville, K., Currie, B.J., and Carapetis, J.R. (2009). A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl. Trop. Dis., 3.","DOI":"10.1371\/journal.pntd.0000554"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"La Vincente, S., Kearns, T., Connors, C., Cameron, S., Carapetis, J., and Andrews, R. (2009). Community management of endemic scabies in remote aboriginal communities of northern Australia: Low treatment uptake and high ongoing acquisition. PLoS Negl. Trop. Dis., 3.","DOI":"10.1371\/journal.pntd.0000444"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Romani, L., Marks, M., Sokana, O., Nasi, T., Kamoriki, B., Wand, H., Whitfeld, M., Engelman, D., Solomon, A.W., and Steer, A.C. (2018). Feasibility and safety of mass drug co-administration with azithromycin and ivermectin for the control of neglected tropical diseases: A single-arm intervention trial. Lancet Glob. Health, in press.","DOI":"10.1016\/S2214-109X(18)30397-8"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Marks, M., Toloka, H., Baker, C., Kositz, C., Asugeni, J., Puiahi, E., Asugeni, R., Azzopardi, K., Diau, J., and Kaldor, J.M. (2018). Randomised trial of community treatment with azithromycin and ivermectin mass drug administration for control of scabies and impetigo. Clin. Infect. Dis., in press.","DOI":"10.1093\/cid\/ciy574"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1756-3305-6-106","article-title":"Opportunities to investigate the effects of ivermectin mass drug administration on scabies","volume":"6","author":"Engelman","year":"2013","journal-title":"Parasit Vectors"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1756-3305-5-299","article-title":"Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis\u2014A rapid assessment methodology to assess impact","volume":"5","author":"Mohammed","year":"2012","journal-title":"Parasit Vectors"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Martin, D., Wiegand, R., Goodhew, B., Lammie, P., Mkocha, H., and Kasubi, M. (2018). Impact of ivermectin mass drug administration for lymphatic filariasis on scabies in eight villages in Kongwa District, Tanzania. Am. J. Trop. Med. Hyg., in press.","DOI":"10.4269\/ajtmh.18-0018"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S1473-3099(18)30347-5","article-title":"Scabies outbreaks in ten care homes for elderly people: A prospective study of clinical features, epidemiology, and treatment outcomes","volume":"18","author":"Cassell","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.mjafi.2012.02.014","article-title":"Mass scabies management in an orphanage of rural community: An experience","volume":"68","author":"Agrawal","year":"2012","journal-title":"Med. J. Armed Forces India"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Beeres, D.T., Ravensbergen, S.J., Heidema, A., Cornish, D., Vonk, M., Wijnholds, L.D., Hendriks, J.J.H., Kleinnijenhuis, J., Omansen, T.F., and Stienstra, Y. (2018). Efficacy of ivermectin mass-drug administration to control scabies in asylum seekers in the Netherlands: A retrospective cohort study between January 2014\u2013March 2016. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006401"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1017\/S0950268816001746","article-title":"The management of scabies outbreaks in residential care facilities for the elderly in England: A review of current health protection guidelines","volume":"144","author":"White","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1017\/S0950268814002143","article-title":"Scabies outbreaks in residential care homes: Factors associated with late recognition, burden and impact. A mixed methods study in England","volume":"143","author":"Hewitt","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1017\/S0950268816000443","article-title":"Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: Lessons learned and moving forward","volume":"144","author":"Mounsey","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"ref_47","unstructured":"WHO Africa (2018, July 06). Ethiopia-Scabies Outbreak Response in Amhara Regional State. Available online: https:\/\/www.afro.who.int\/news\/ethiopia-scabies-outbreak-response-amhara-regional-state."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMct0910329","article-title":"Permethrin and ivermectin for scabies","volume":"362","author":"Currie","year":"2010","journal-title":"New Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s13071-015-1159-9","article-title":"Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: A comparative modelling analysis","volume":"8","author":"Stolk","year":"2015","journal-title":"Parasit Vectors"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1473-3099(16)30467-4","article-title":"Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: A modelling study","volume":"17","author":"Irvine","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lydeamore, M.J., Campbell, P.T., Regan, D.G., Tong, S.Y.C., Andrews, R.M., Steer, A.C., Romani, L., Kaldor, J.M., McVernon, J., and McCaw, J.M. (2018). A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination. Math. Biosci., in press.","DOI":"10.1016\/j.mbs.2018.08.007"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/archdischild-2017-314505","article-title":"Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?","volume":"103","author":"Wilkins","year":"2018","journal-title":"Arch. Dis. Child"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1360-2276.2003.01142.x","article-title":"Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis","volume":"8","author":"Gyapong","year":"2003","journal-title":"Trop. Med. Int. Health"},{"key":"ref_54","first-page":"268","article-title":"Problems in diagnosing scabies, a global disease in human and animal populations","volume":"20","author":"Walton","year":"2007","journal-title":"Am. Soc. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.csbj.2017.02.003","article-title":"Re-imagining the future of diagnosis of neglected tropical diseases","volume":"15","author":"Peeling","year":"2017","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Mitj\u00e0, O., Marks, M., Bertran, L., Kollie, K., Argaw, D., Fahal, A., Fitzpatrick, C., Fuller, C., Garcia-Izquierdo, B., and Hay, R. (2017). Integrated control and management of neglected tropical diseases. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005136"},{"key":"ref_57","unstructured":"World Health Organization (2018, August 12). Recognizing Neglected Tropical Diseases through Changes on the Skin: A Training Guide for Front-Line Health Workers. Available online: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272723\/9789241513531-eng.pdf."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1365-4632.2012.05546.x","article-title":"Specialized dermatological care for marginalized populations and education at the primary care level: Is community dermatology a feasible proposal?","volume":"51","author":"Estrada","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-4632.2011.04954.x","article-title":"Managing skin disease in resource-poor environments-the role of community-oriented training and control programs","volume":"50","author":"Hay","year":"2011","journal-title":"Int. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Faye, O., Bagayoko, C., Dicko, A., Ciss\u00e9, L., Berth\u00e9, S., Traor\u00e9, B., Fofana, Y., Niang, M., Traor\u00e9, S., and Karabinta, Y. (2018). A teledermatology pilot programme for the management of skin diseases in primary health care centres: Experiences from a resource-limited country (Mali, West Africa). Trop. Med. Infect. Dis., 3.","DOI":"10.3390\/tropicalmed3030088"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1086\/421776","article-title":"First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei","volume":"39","author":"Currie","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/17460913.3.1.57","article-title":"Scabies: Molecular perspectives and therapeutic implications in the face of emerging drug resistance","volume":"3","author":"Mounsey","year":"2008","journal-title":"Future Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jphp.12368","article-title":"Ectoparasites of medical and veterinary importance: Drug resistance and the need for alternative control methods","volume":"67","author":"McNair","year":"2015","journal-title":"J. Pharm Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Khalil, S., Abbas, O., Kibbi, A.G., and Kurban, M. (2017). Scabies in the age of increasing drug resistance. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005920"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Opoku, N.O., Bakajika, D.K., Kanza, E.M., Howard, H., Mambandu, G.L., Nyathirombo, A., Nigo, M.M., Kasonia, K., Masembe, S.L., and Mumbere, M. (2018). Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: A randomised, controlled, double-blind phase 3 trial. Lancet, in press.","DOI":"10.1016\/S0140-6736(17)32844-1"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/0091270003257456","article-title":"The antiparasitic moxidectin: Safety, tolerability, and pharmacokinetics in humans","volume":"43","author":"Cotreau","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Mounsey, K.E., Bernigaud, C., Chosidow, O., and McCarthy, J.S. (2016). Prospects for moxidectin as a new oral treatment for human scabies. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004389"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Bernigaud, C., Fang, F., Fischer, K., Lespine, A., Aho, L., Dreau, D., Kelly, A., Sutra, J.F., Moreau, F., and Lilin, T. (2016). Preclinical study of single-dose moxidectin, a new oral treatment for scabies: Efficacy, safety, and pharmacokinetics compared to two-dose ivermectin in a porcine model. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0005030"},{"key":"ref_69","unstructured":"Medicines Development for Global Health (2018, August 03). Moxidectin Program. Available online: https:\/\/www.medicinesdevelopment.com\/development-programs.htm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jcpt.12631","article-title":"Scabies - An ancient itch that is still rampant today","volume":"42","author":"Thomas","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.pt.2016.08.005","article-title":"Opportunities for integrated control of neglected tropical diseases that affect the skin","volume":"32","author":"Engelman","year":"2016","journal-title":"Trends Parasitol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/trstmh\/trx008","article-title":"Skin NTDs: An opportunity for integrated care","volume":"110","author":"Hay","year":"2016","journal-title":"Trans. Royal Soc. Trop. Med. Hyg."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Yotsu, R.R., Kouadio, K., Vagamon, B., N\u2019Guessan, K., Akpa, A.J., Yao, A., Ake, J., Abbet, R., Tchamba Agbor Agbor, B., and Bedimo, R. (2018). Skin disease prevalence study in schoolchildren in rural Cote d\u2019Ivoire: Implications for integration of neglected skin diseases (skin NTDs). PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006489"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/civ882","article-title":"Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of bancroftian filariasis","volume":"62","author":"Thomsen","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Fischer, P.U., King, C.L., Jacobson, J.A., and Weil, G.J. (2017). Potential value of triple drug therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) to accelerate elimination of lymphatic filariasis and onchocerciasis in Africa. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005163"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1093\/inthealth\/ihw002","article-title":"Leaving no one behind: A neglected tropical disease indicator and tracers for the Sustainable Development Goals","volume":"8","author":"Fitzpatrick","year":"2016","journal-title":"Int. Health"}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/3\/3\/98\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:18:55Z","timestamp":1760195935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/3\/3\/98"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":76,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["tropicalmed3030098"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed3030098","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]}}}